X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE FRESENIUS KABI ONCO. SUVEN LIFE/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 16.2 22.1 73.4% View Chart
P/BV x 3.0 3.1 96.8% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 SUVEN LIFE   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
FRESENIUS KABI ONCO.
Mar-13
SUVEN LIFE/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs339176 192.3%   
Low Rs14479 183.9%   
Sales per share (Unadj.) Rs39.237.7 104.1%  
Earnings per share (Unadj.) Rs7.55.1 146.5%  
Cash flow per share (Unadj.) Rs8.86.7 130.5%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs49.042.5 115.2%  
Shares outstanding (eoy) m127.28158.23 80.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.23.4 182.2%   
Avg P/E ratio x32.425.0 129.5%  
P/CF ratio (eoy) x27.518.9 145.4%  
Price / Book Value ratio x4.93.0 164.8%  
Dividend payout %26.80-   
Avg Mkt Cap Rs m30,73220,135 152.6%   
No. of employees `0001.01.2 82.8%   
Total wages/salary Rs m416703 59.2%   
Avg. sales/employee Rs Th5,236.15,176.2 101.2%   
Avg. wages/employee Rs Th436.5610.4 71.5%   
Avg. net profit/employee Rs Th995.5699.6 142.3%   
INCOME DATA
Net Sales Rs m4,9955,963 83.8%  
Other income Rs m19418 1,075.0%   
Total revenues Rs m5,1895,981 86.8%   
Gross profit Rs m1,2331,430 86.2%  
Depreciation Rs m167258 64.8%   
Interest Rs m54-26 -208.5%   
Profit before tax Rs m1,2051,216 99.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m255342 74.5%   
Profit after tax Rs m950806 117.8%  
Gross profit margin %24.724.0 102.9%  
Effective tax rate %21.228.1 75.2%   
Net profit margin %19.013.5 140.7%  
BALANCE SHEET DATA
Current assets Rs m4,9865,102 97.7%   
Current liabilities Rs m1,0422,385 43.7%   
Net working cap to sales %79.045.6 173.3%  
Current ratio x4.82.1 223.7%  
Inventory Days Days61150 40.7%  
Debtors Days Days39113 34.5%  
Net fixed assets Rs m3,1265,148 60.7%   
Share capital Rs m127158 80.5%   
"Free" reserves Rs m3,7176,556 56.7%   
Net worth Rs m6,2366,732 92.6%   
Long term debt Rs m432952 45.4%   
Total assets Rs m8,07910,388 77.8%  
Interest coverage x23.2-45.8 -50.7%   
Debt to equity ratio x0.10.1 49.0%  
Sales to assets ratio x0.60.6 107.7%   
Return on assets %12.47.5 165.5%  
Return on equity %15.212.0 127.2%  
Return on capital %18.914.6 129.3%  
Exports to sales %87.574.5 117.5%   
Imports to sales %12.224.8 49.4%   
Exports (fob) Rs m4,3714,441 98.4%   
Imports (cif) Rs m6111,477 41.3%   
Fx inflow Rs m4,6665,298 88.1%   
Fx outflow Rs m9421,772 53.2%   
Net fx Rs m3,7243,525 105.6%   
CASH FLOW
From Operations Rs m9221,274 72.4%  
From Investments Rs m-619-1,204 51.4%  
From Financial Activity Rs m-698-196 356.1%  
Net Cashflow Rs m-396-126 313.3%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 0.0 0.3 -  
FIIs % 0.0 9.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 9.1 401.1%  
Shareholders   37,287 42,599 87.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 18, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - JUBILANT LIFE SCIENCES COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS